14:00u Sessie 2: Marta Lobato, vascular surgeon, Hospitel Universitario de Cruces, Bilbao

Biografie:
Vascular and endovascular Surgery Consultant in Hospital Universitario de Cruces (Bilbao-Spain) since 2010. My Department is considered a first line Unit in the endovascular management of CLTI ( particularly in the BTK-BTA segments). I developed my Vascular Fellowship Programme in Hospital Universitario Doce de Octubre (Madrid) and thereafter completed my training with stage in HOSPITAL DU NORD. ETIENNE.(FRANCE), UNIVERSITÄTS SPITAL ZURICH. (SWITZERLAND), ST FRANZISKUS HOSPITAL MÜNSTER.(GERMANY)

For the last ten years my activity has been mainly focused in the endovascular treatment of the lower limb, routinely performing complex CTO
revascularizations, including any sort of bidirectional access, transcollateral approaches, plantar loop or venous arterialization. My Unit has presented multiple communications in well recognized international symposiums and has published many papers in first line journals of my speciality.

REVIEWER of Journal of Endovascular Therapy, Annals of Vascular Surgery and Journal of Critical Limb Ischemia

Sessie informatie:
Endovascular treatment is often considered the best option for addressing issues in the below-the-knee (BTK) and below-the-ankle (BTA) arteries, particularly in patients with CLTI  Several factors contribute to the decision to pursue endovascular intervention:

1.Anatomical Considerations: Endovascular techniques are particularly advantageous for patients with complex vascular anatomy, including long occlusions, tortuous vessels, or small-caliber arteries. These techniques allow for targeted treatment with minimal disruption to surrounding tissues.

2.Patient Profile: Endovascular treatment is ideal for patients who are at high risk for surgical complications due to comorbidities such as diabetes, renal insufficiency, or advanced age. The minimally invasive nature of endovascular procedures reduces recovery time and hospital stays.

3. Symptom Severity: Patients presenting with non-healing ulcers are prime candidates for endovascular therapy. The goal is to restore blood flow to the affected areas, alleviating symptoms and preventing limb loss.

4. Technical Success Rates: Advances in endovascular techniques, including balloon angioplasty, stenting, and drug-eluting technologies, have improved the success rates of these procedures. High rates of patency and limb salvage make endovascular options attractive.

5. Multidisciplinary Approach: Endovascular treatment is often part of a comprehensive management strategy that includes medical therapy and lifestyle modifications. A multidisciplinary team can tailor the approach based on individual patient needs.

In summary, endovascular treatment is the best option for BTK-BTA arteries when anatomical complexity, patient risk factors, symptom severity, and the potential for successful outcomes align, making it a preferred choice for managing critical limb ischemia and improving quality of life.